Howe & Rusling Inc Macrogenics Inc Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $54 - $93	18 Added 66.67%	45 $0
Q1 2022 May 10, 2022	SELL	$8.12 - $16.9 $64 - $135	-8 Reduced 22.86%	27 $0
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $78 - $114	4 Added 12.9%	35 $1,000
Q1 2021 May 13, 2021	SELL	$18.99 - $33.2 $113 - $199	-6 Reduced 16.22%	31 $1,000
Q4 2020 Feb 08, 2021	BUY	$19.41 - $26.0 $718 - $962	37 New	37 $1,000

130

55.3M

87.3K

228K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $157M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.